Evidence map›Paper›PMID 40687255›Full record

ArticleTranslational cancer research2025

Guanine monophosphate synthase-mediated nuclear and mitochondrial communication in the progression of gastric cancer.

Xiaoshu Guo, Keyuan Xiao, Jiping Gong, Yu Wang, Liang Zong, Jiaoping Pan, Fan Yang, Hui Mi, Yiqiang Zhang, Baolian Ma and 3 more

Abstract read
In one paragraph

Article in Translational cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Xiaoshu Guo *Department of Physiology, Department of Fundamental Medicine, Changzhi Medical College, Changzhi, China.
Keyuan Xiao *Department of Gastrointestinal Surgery & Shanxi Province Clinical Medical Research Center for Malignant Tumors (Esophagogastric Junction Carcinoma), Affiliated Changzhi People's Hospital, Third Clinical College, Changzhi Medical College, Changzhi, China.
Jiping GongDepartment of Anesthesiology, Xinxiang Central Hospital, Fourth Clinical College, Henan Medical University, Xinxiang, China.
Yu WangDepartment of Pathology, Affiliated Changzhi People's Hospital, Third Clinical College, Changzhi Medical College, Changzhi, China.
Liang ZongDepartment of Gastrointestinal Surgery & Shanxi Province Clinical Medical Research Center for Malignant Tumors (Esophagogastric Junction Carcinoma), Affiliated Changzhi People's Hospital, Third Clinical College, Changzhi Medical College, Changzhi, China.
Jiaoping PanDepartment of Pathology, Affiliated Changzhi People's Hospital, Third Clinical College, Changzhi Medical College, Changzhi, China.
Fan YangDepartment of Gastrointestinal Surgery & Shanxi Province Clinical Medical Research Center for Malignant Tumors (Esophagogastric Junction Carcinoma), Affiliated Changzhi People's Hospital, Third Clinical College, Changzhi Medical College, Changzhi, China.
Hui MiDepartment of Clinical Laboratory, Affiliated Changzhi People's Hospital, Third Clinical College, Changzhi Medical College, Changzhi, China.
Yiqiang ZhangDepartment of Biochemistry, Department of Fundamental Medicine, Changzhi Medical College, Changzhi, China.
Baolian MaDepartment of Pharmacy, Changzhi Medical College, Changzhi, China.
Lei SunDepartment of Clinical Laboratory, Affiliated Changzhi People's Hospital, Third Clinical College, Changzhi Medical College, Changzhi, China.
Qilong LiDepartment of Gastrointestinal Surgery & Shanxi Province Clinical Medical Research Center for Malignant Tumors (Esophagogastric Junction Carcinoma), Affiliated Changzhi People's Hospital, Third Clinical College, Changzhi Medical College, Changzhi, China.
Wenqing HuDepartment of Gastrointestinal Surgery & Shanxi Province Clinical Medical Research Center for Malignant Tumors (Esophagogastric Junction Carcinoma), Affiliated Changzhi People's Hospital, Third Clinical College, Changzhi Medical College, Changzhi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Aberrant regulation of guanine monophosphate synthase (GMPS) and serine hydroxymethyltransferase 2 (SHMT2) has been associated with abnormal cell growth, survival, and death in cancer models. This research endeavors to elucidate how the interplay between GMPS and SHMT2 in the nucleus and mitochondria can affect the viability, programmed cell death, and mitochondrial self-degradation of neoplastic cells. Methods: The study utilized bioinformatics analysis to investigate the interaction mechanism between GMPS and SHMT2. Subsequently, enzyme-linked immunosorbent assay was utilized to assess the levels of GMPS, SHMT2, and TP53 in serum samples obtained from both gastric cancer (GC) patients and control subjects. Furthermore, the study examined the impact of GMPS knockout on cell characteristics, cellular mitochondrial reactive oxygen species (ROS) and 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolylcarbocyanine iodide (JC-1) levels, as well as the expression of SHMT2, CASP3, and TP53 in GC cell lines AGS, MGC-803, and HGC-27. Additionally, the study detected protein expression levels of TP53, CASP3, and PINK1. Results: The findings of the bioinformatics analysis revealed a significant upregulation of GMPS, SHMT2, TP53, and CASP3 expression levels in patients diagnosed with gastric carcinoma compared to those in healthy individuals. Additionally, a notable increase in GMPS and SHMT2 expression was observed in cancerous tissues in comparison to adjacent para-carcinoma tissues. Furthermore, the serum levels of GMPS and SHMT2 exhibited significant correlations with the extent of GC invasion, tumor-node-metastasis classification staging, and the administration of chemotherapy (P<0.05); the serum level of TP53, however, was significantly correlated only with the extent of GC invasion and whether chemotherapy was administered (P<0.05). Upon transfection with the pLenti-GMPS-sgRNA plasmid, a notable decrease in the proliferation and migration capabilities of AGS, MGC-803, and HGC-27 cells was observed (P<0.05). Subsequent GMPS knockout resulted in elevated levels of mitochondrial ROS in AGS, MGC-803, and HGC-27 cells, with a particularly significant difference noted in HGC-27 cells. Furthermore, spatial interactions between GMPS and SHMT2, CASP3, and TP53 were identified. Following GMPS knockout, the population of double-positive cells for SHMT2, CASP3, and TP53 experienced a significant reduction (P<0.001). Following GMPS knockout, the protein expression levels of TP53, P-TP53 (Ser15), CASP3, PINK1, and PARK2 were upregulated in AGS cells, while the expression levels of SHMT2, AKT1, and CASP9 proteins were downregulated. Conclusions: The study identifies GMPS as a novel target for the prognosis and chemotherapy sensitivity of GC patients. The interaction between GMPS and SHMT2 enhances the exchange of nuclear and mitochondrial information in GC cells.

Indexed as

chemotherapy sensitivityGastric cancer (GC)guanine monophosphate synthase (GMPS)mitochondria

Identifiers

PMID40687255
PMCPMC12268878

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.